+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias



Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias



Pacing and Clinical Electrophysiology 26(1p2): 461-465



Eighty-nine patients with a documented history of atrial tachyarrhythmias or fibrillation (AF) received a cardioverter defibrillator designed to selectively differentiate and treat atrial and ventricular arrhythmias. Twenty-two patients received a coronary sinus lead and, therefore, could use a separate shock vector for selective treatment of atrial tachyarrhythmias/AF. The device is designed to treat tachyarrhythmias with antitachycardia pacing (ATP) and/or shock therapy using an atrial and/or a ventricular shock vector. Patients underwent induction and shock termination of atrial or dual tachyarrhythmias (AF/VF) to verify proper device function and to measure the arrhythmia detection time with enhancements and preventive algorithms programmed On and Off, respectively. Detection time for 329 VF inductions was 2.41 +/- 0.64 seconds with enhancements On and 2.29 +/- 0.47 with enhancements Off (NS). At implant or predischarge, 283 AF and/or AF/VF (121 atrial and 162 atrial/ventricular fibrillation) were induced. Shock conversion efficacy was 89.8% with AF conversion energies ranging from 0.9 to 27 J. Thirteen of the 23 patients had atrial shock conversions using the separate shock vector with an average conversion energy of 1.9 +/- 1.4 J. (range 0.5-5 J). During follow-up the efficacy of ATP on atrial tachyarrhythmias was 59% and the efficacy of delivered shocks on AF was 85%. This new dual chamber cardioverter defibrillator appropriately detected and classified atrial arrhythmias, and shock therapy for AF was highly effective. The detection algorithm differentiated atrial tachyarrhythmia/AF and did not delay VF detection. The separate shock vector converted induced AF with energies ranging from 0.6 to 5 J.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048993405

Download citation: RISBibTeXText

PMID: 12687868

DOI: 10.1046/j.1460-9592.2003.00072.x


Related references

Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104(8): 887-892, 2001

The efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter-defibrillator. Journal of the American College of Cardiology 37(2 Suppl. A): 95A, 2001

Dual-Chamber Implantable Cardioverter Defibrillator vs Single-Chamber Implantable Cardioverter Defibrillator High incidence of device and lead related complications in Dual-Chamber Implantable Cardioverter Defibrillator. Journal of the American College of Cardiology 35(2 Suppl A): 127A, 2000

P1636Incidence and predictors of atrial arrhythmias in patients with a dual chamber implantable cardioverter-defibrillator followed by remote monitoring. Ep Europace 19(Suppl_3): iii352-iii353, 2017

Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance. Journal of Interventional Cardiac Electrophysiology 12(2): 149-156, 2005

A new algorithm to differentiate between atrial and ventricular arrhythmias Preliminary experience with a new double-chamber implantable cardioverter/defibrillator. European Heart Journal 19(ABST Suppl. ): 75, 1998

Use of atrial and ventricular electrograms from a dual chamber implantable cardioverter defibrillator to elucidate a complex dysrhythmia. Pacing and Clinical Electrophysiology 21(10): 2002-2004, 1998

Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator. Journal of Cardiovascular Electrophysiology 11(12): 1309-1319, 2000

Is this pacemaker working properly? Prolongation of the atrial escape interval following activation of the ventricular safety pacing algorithm in a dual-chamber implantable cardioverter defibrillator with atrial-based, lower rate timing. Canadian Journal of Cardiology 24(7): E43-E44, 2008

Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry. Yearbook of Cardiology 2012: 462-463, 2012

Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. Journal of the American College of Cardiology 58(10): 1007-1013, 2011

Dual-chamber implantable cardioverter-defibrillator. Is it useful in patient with permanent atrial fibrillation?. Clinical Case Reports 4(8): 747-751, 2016

Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. Journal of Cardiovascular Electrophysiology 11(11): 1196-1205, 2000

Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation 101(8): 878-885, 2000

Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrthymias in patients with a new implantable dual chamber cardioverter-defibrillator. Circulation 104(17 Suppl.): II 383, 2001